Cargando…
Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial
BACKGROUND: We showed excellent adherence and satisfaction with our telehealth care (TC) approach for COPD. Here, the results of a consecutive randomized controlled trial are presented. METHODS: Patients were randomly assigned to TC or standard care (SC). During TC, patients answered six daily quest...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986739/ https://www.ncbi.nlm.nih.gov/pubmed/33428219 http://dx.doi.org/10.1111/joim.13230 |
_version_ | 1783668502665625600 |
---|---|
author | Rassouli, F. Germann, A. Baty, F. Kohler, M. Stolz, D. Thurnheer, R. Brack, T. Kähler, C. Widmer, S. Tschirren, U. Sievi, N. A. Tamm, M. Brutsche, M. H. |
author_facet | Rassouli, F. Germann, A. Baty, F. Kohler, M. Stolz, D. Thurnheer, R. Brack, T. Kähler, C. Widmer, S. Tschirren, U. Sievi, N. A. Tamm, M. Brutsche, M. H. |
author_sort | Rassouli, F. |
collection | PubMed |
description | BACKGROUND: We showed excellent adherence and satisfaction with our telehealth care (TC) approach for COPD. Here, the results of a consecutive randomized controlled trial are presented. METHODS: Patients were randomly assigned to TC or standard care (SC). During TC, patients answered six daily questions online, and focused on the early recognition of exacerbations, in addition to SC. RESULTS: The mean increase in COPD assessment test (CAT) was 1.8 vs. 3.6 points/year in the TC and SC groups, respectively (P = 0.0015). Satisfaction with care (VAS) at baseline was 8.2; at the end of SC, 8.5 (P = 0.062); and after TC, 8.8 (P < 0.001). We detected significantly more moderate exacerbations during TC. CONCLUSION: Whilst receiving TC, the slope of the CAT increase – an indicator of the naturally progressive course of COPD – was reduced by 50%. Satisfaction with care increased with TC. The higher number of detected moderate exacerbations probably indicates a higher diagnostic sensitivity than without TC. |
format | Online Article Text |
id | pubmed-7986739 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79867392021-03-25 Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial Rassouli, F. Germann, A. Baty, F. Kohler, M. Stolz, D. Thurnheer, R. Brack, T. Kähler, C. Widmer, S. Tschirren, U. Sievi, N. A. Tamm, M. Brutsche, M. H. J Intern Med Brief Reports BACKGROUND: We showed excellent adherence and satisfaction with our telehealth care (TC) approach for COPD. Here, the results of a consecutive randomized controlled trial are presented. METHODS: Patients were randomly assigned to TC or standard care (SC). During TC, patients answered six daily questions online, and focused on the early recognition of exacerbations, in addition to SC. RESULTS: The mean increase in COPD assessment test (CAT) was 1.8 vs. 3.6 points/year in the TC and SC groups, respectively (P = 0.0015). Satisfaction with care (VAS) at baseline was 8.2; at the end of SC, 8.5 (P = 0.062); and after TC, 8.8 (P < 0.001). We detected significantly more moderate exacerbations during TC. CONCLUSION: Whilst receiving TC, the slope of the CAT increase – an indicator of the naturally progressive course of COPD – was reduced by 50%. Satisfaction with care increased with TC. The higher number of detected moderate exacerbations probably indicates a higher diagnostic sensitivity than without TC. John Wiley and Sons Inc. 2021-01-11 2021-03 /pmc/articles/PMC7986739/ /pubmed/33428219 http://dx.doi.org/10.1111/joim.13230 Text en © 2021 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Reports Rassouli, F. Germann, A. Baty, F. Kohler, M. Stolz, D. Thurnheer, R. Brack, T. Kähler, C. Widmer, S. Tschirren, U. Sievi, N. A. Tamm, M. Brutsche, M. H. Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial |
title | Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial |
title_full | Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial |
title_fullStr | Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial |
title_full_unstemmed | Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial |
title_short | Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial |
title_sort | telehealth mitigates copd disease progression compared to standard of care: a randomized controlled crossover trial |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986739/ https://www.ncbi.nlm.nih.gov/pubmed/33428219 http://dx.doi.org/10.1111/joim.13230 |
work_keys_str_mv | AT rassoulif telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT germanna telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT batyf telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT kohlerm telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT stolzd telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT thurnheerr telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT brackt telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT kahlerc telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT widmers telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT tschirrenu telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT sievina telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT tammm telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial AT brutschemh telehealthmitigatescopddiseaseprogressioncomparedtostandardofcarearandomizedcontrolledcrossovertrial |